Shapes of membrane permeability–lipophilicity curves: Extension of theoretical models with an aqueous pore pathway

Adson, 1994, Quantitative approaches to delineate paracellular diffusion in cultured epithilial cell monolayers, J. Pharm. Sci., 83, 1529, 10.1002/jps.2600831103 Adson, 1995, Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: Uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers, J. Pharm. Sci., 84, 1197, 10.1002/jps.2600841011 Austel, V., Kutter, E., 1983. Absorption, distribution, and metabolism of drugs. In: Topliss, J.G. (Ed.), Quantitative Structure-Activity Relationships of Drugs. Academic Press, London, pp. 437–496. Burton, 1996, How structural features influence the biomembrane permeability of peptides, J. Pharm. Sci., 85, 1336, 10.1021/js960067d Camenisch, G., 1996. Drug transport across membranes: Structure-property correlations in the prediction of passive membrane permeation. Ph.D. Thesis, ETH Zürich, Switzerland. Camenisch, 1996, Review of theoretical passive drug absorption models: Historical background, recent developments and limitations, Pharm. Acta Helv., 71, 309, 10.1016/S0031-6865(96)00031-3 Camenisch, G., Alsenz, J., Van de Waterbeemd, H., Folkers, G. (in press) Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur. J. Pharm. Sci. Chan, 1996, Physicochemical and drug-delivery considerations for oral drug bioavailability, Drug Discov. Today, 1, 461, 10.1016/1359-6446(96)10039-8 Collander, 1950, The distribution of organic compounds between iso-butanol and water, Acta Chem. Scand., 4, 1085, 10.3891/acta.chem.scand.04-1085 Collander, 1951, The partition of organic compounds between higher alcohols and water, Acta Chem. Scand., 5, 774, 10.3891/acta.chem.scand.05-0774 Dearden, J.C. (1990) Molecular structure and drug transport. In: Hansch, C., Sammes, P.G., Taylor, J.B., Ramsden, C.R. (Eds.), Comprehensive Medicinal Chemistry, vol. 4. Pergamon Press, New York, pp. 375–411. De Haan, F.H.N., 1985. The Role of Drug Transport in QSAR. Ph.D. Thesis, University of Leiden, The Netherlands. De Haan, F.H.N., Jansen, A.C.A., 1985. Rationally designed model with general applicability for absorption by passive diffusion. In: Seydel, J.K. (Ed.), QSAR and Strategies in the Design of Bioactive Compounds. VCH, Weinheim, pp. 198–204. Flynn, 1974, Mass transport phenomena and models: Theoretical concepts, J. Pharm. Sci., 63, 479, 10.1002/jps.2600630403 Garrigues, 1990, Gastric absorption of acidic xenobiotics in the rat: Biophysical interpretation of an apparently atypical behaviour, Int. J. Pharm., 64, 127, 10.1016/0378-5173(90)90261-2 Hansch, 1969, A quantitative approach to biochemical structure-activity relationships, Accounts Chem. Res., 2, 232, 10.1021/ar50020a002 Ho, 1971, Quantitative interpretation of in vivo buccal absorption of n-alkanoic acids by the physical model approach, J. Pharm. Sci., 60, 537, 10.1002/jps.2600600404 Ho, N.F.H., Park, J.Y., Morozowich, W., Higuchi, W.I., 1977. Physical model approach to the design of drugs with improved intestinal absorption. In: Roche, E.B. (Ed.), Design of Biopharmaceutical Properties through Prodrugs and Analogs. APhA/APS, Washington, DC, pp. 136–227. Ho, N.F.H., Park, J.Y., Ni, P.F. and Higuchi, W.I., 1983. Advancing quantitative and mechanistic approaches in interfacing gastrointestinal drug absorption studies in animals and man. In: Crouthamel, W.G., Sarapu, A. (Eds.), Animal Models for Oral Drug Delivery in Man: In Situ and In Vivo Approaches. APhA/APS, Washington, DC, pp. 27–106. Ho, 1995, A biophysical model of passive and polarized active transport processes in Caco-2 cells: Approaches to uncoupling apical and basolateral membrane events in the intact cell, J. Pharm. Sci., 84, 21, 10.1002/jps.2600840107 Kakemi, 1967, Absorption and excretion of drugs: XXX. Absorption of barbituric acid derivates from rat stomach, Chem. Pharm. Bull., 17, 1534, 10.1248/cpb.15.1534 Kubinyi, 1976, Quantitative structure-activity relationships: IV. Non-linear dependence of biological activity on hydrophobic character: A new model, Arzneim. Forsch. (Drug Res.), 26, 1991 Kubinyi, 1979, Lipophilicity and drug activity, Progr. Drug Res., 23, 97 Leahy, D.E., Lynch, J., Taylor, D.C., 1989. Mechanisms of absorption of small molecules. In: Prescott, L.F., Nimmo, W.S. (Eds.), Novel Drug Delivery and its Therapeutic Application. John Wiley & Sons, New York, pp. 33–44. Lee, 1997, Percutaneous absorption: a multiple pathway model, J. Control. Release, 45, 141, 10.1016/S0168-3659(96)01567-2 Lennernäs, 1995, Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?, Pharm. Res., 12, 1573, 10.1023/A:1016220428705 Leo, 1971, Partition coefficients and their uses, Chem. Rev., 71, 525, 10.1021/cr60274a001 Lieb, 1971, The molecular basis of simple diffusion within biological membranes, Curr. Top. Membr. Transp., 2, 1, 10.1016/S0070-2161(08)60340-8 Lovering, 1974, Diffusion layer effects on permeation of phenylbutazone through polydimethylsiloxane, J. Pharm. Sci., 63, 1399, 10.1002/jps.2600630914 Ong, 1996, Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability, J. Chromatogr., A 728, 113, 10.1016/0021-9673(95)00837-3 Pauletti, 1996, The effect of charge and conformational flexibility on the pathway of permeation of model hexapeptides across Caco-2 cell monolayers in unperturbed and perturbed states, Pharm Res. (Suppl.), 13, S235 Plá-Delfina, 1981, Intestinal absorption-partition relationships: A tentative functional nonlinear model, J. Pharmacokinet. Biopharm., 9, 191, 10.1007/BF01068082 Pliska, V., Testa, B., Van de Waterbeemd, H. (Eds.), 1996. Lipophilicity in Drug Action and Toxicology. VCH, Weinheim. Raub, 1993, Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers, J. Drug Target., 1, 269, 10.3109/10611869308996085 Reymond, 1996, Mechanism of transfer of a basic drug across the water/1,2-dichlorethane interface: The case of quinidine, Helv. Chim. Acta, 79, 101, 10.1002/hlca.19960790111 Scheuplein, 1966, Analysis of permeability data for the case of parallel diffusion pathway, Biophys. J., 6, 1, 10.1016/S0006-3495(66)86636-5 Shore, 1957, The gastric secretions of drugs: A pH partition hypothesis, J. Pharm. Exp. Ther., 119, 361 Stehle, 1972, In vitro model for transport of solutes in three- phase system I: Theoretical principles, J. Pharm. Sci., 61, 1922, 10.1002/jps.2600611208 Van de Waterbeemd, 1981, Transport in QSAR V: Application of the interfacial drug tranfer model, Pharm. Weekbl. Sci. Ed., 3, 587 Van de Waterbeemd, 1980, Transport in QSAR II: Rate-equilibrium relationships and the interfacial transfer of drugs, Eur. J. Med. Chem., 3, 279 Van de Waterbeemd, 1981, Transport in QSAR IV: The interfacial transfer model. Relationships between partition coefficients and rate constants of drug partitioning, Pharm. Weekbl. Sci. Ed., 3, 224 Van de Waterbeemd, 1996, Estimation of Caco-2 cell permeability using calculated molecular descriptors, Quant. Struct. Act. Relat., 15, 480, 10.1002/qsar.19960150604 Van de Waterbeemd, H., Kansy, M., Wagner, B., Fischer, H., 1996b. Lipophilicity measurement by reversed-phase high performance liquid chromatography (RP- HPLC). In: Pliska, V., Testa, B., Van de Waterbeemd, H. (Eds.), Lipophilicity in Drug Action and Toxicology. VCH, Weinheim, pp. 73–87. Wacher, 1996, Active secretion and enterocytic drug metabolism barriers to drug absorption, Adv. Drug Deliv. Rev., 20, 99, 10.1016/0169-409X(95)00127-S Wagner, 1973, Quantitation of rate of gastrointestinal and buccal absorption of acidic and basic drugs based on extraction theory, J. Pharmacokinet. Biopharm., 1, 23, 10.1007/BF01060026 Walter, 1986, Permeability of small nonelectrolytes through lipid bilayer membranes, J. Membr. Biol., 90, 207, 10.1007/BF01870127 Xiang, 1994, The relationship between permeant size and permeability in lipid bilayer membranes, J. Membr. Biol., 140, 111, 10.1007/BF00232899 Yalkowsky, 1974, Effects of alkyl chain length on biological activity: Alkyl p-aminobenzoate-induced narcosis in goldfish, J. Pharm. Sci., 63, 691, 10.1002/jps.2600630509